Physician profile
John L Roberson
NPI 1154303105
$10,018.18
in general payments reported to CMS, 2019-2025
31 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,950 · 2020: $486 · 2021: $4,913 · 2022: $1,043 · 2023: $588 · 2024: $422 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $6,278.38 | 2019-2024 | Cabtreo, Arazlo |
| Stryker Corporation | $1,678.32 | 2021-2025 | Ortholoc 2 Lapifuse, Asnis, Sonicanchor |
| Musculoskeletal Transplant Foundation INC. | $458.73 | 2021 | |
| Paratek Pharmaceuticals, INC. | $191.83 | 2019-2025 | Nuzyra |
| Abbvie INC. | $147.08 | 2021-2025 | |
| Horizon Therapeutics Plc | $118.64 | 2019-2021 | |
| Amgen INC. | $116.76 | 2024-2025 | Krystexxa |
| Medtronic, INC. | $114.73 | 2022 | |
| Smith+Nephew, INC. | $112.05 | 2020-2022 | |
| Paragon 28, INC. | $111.59 | 2025 | Grappler |
| Wright Medical Technology, INC. | $105.16 | 2019 | |
| Melinta Therapeutics, LLC | $74.17 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $55.39 | 2022 | |
| Kerecis Limited | $44.50 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $39.72 | 2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $39.28 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Zyla Life Sciences, INC. | $38.77 | 2019-2020 | |
| Organogenesis INC. | $34.35 | 2025 | Apligraf |
| Globus Medical, INC. | $32.24 | 2025 | Senza |
| Abbott Laboratories | $28.81 | 2022-2023 | Proclaim |
| Merck Sharp & Dohme LLC | $27.60 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.83 | 2025 | |
| Grt US Holding, INC. | $20.94 | 2021 | |
| Solventum Corporation | $20.85 | 2024 | Activ.A.C. Ion Progress |
| Orthofix Medical, INC. | $19.57 | 2023 | Physio-Stim |
| Heron Therapeutics, INC. | $19.30 | 2021 | |
| Dentsply Sirona INC | $14.57 | 2023 | Suresmile |
| Ermi LLC | $14.24 | 2021 | |
| Alfasigma USA, INC. | $12.84 | 2022 | |
| Djo, LLC | $12.63 | 2019 | |
| Metric Medical Devices, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roberson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.